BeStock  
Stocks › Biotechnology › SLDB

Solid Biosciences SLDB

US equityMarket cap rank #3471Biotechnology
$6.85 −$0.07 (-1.01%)
Market closed · Oct 8, 7:00 am ET · Last extended-hours $6.85 0.00%
Open$6.76
Prev close$6.92
Day range$6.69 – $6.98
Volume744.7K
Market cap$734.49M
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts10
Average target$19.00+177.4% vs. price
  • Buy 100%
Low $11.00Now $6.85Avg $19.00High $26.00

Recent rating changes

The last 20 actions on file set price targets from $11.00 to $26.00, averaging $19.11.

DateFirmRatingTarget
30 Sep 2026 Piper Sandler BUY $18.00
16 Sep 2026 Leerink Partners BUY $20.00
16 Sep 2026 RBC Capital BUY $18.00
15 Sep 2026 Cantor Fitzgerald BUY $26.00
14 Sep 2026 H.C. Wainwright BUY $25.00
10 Sep 2026 Citi BUY $14.00
26 Aug 2026 Cantor Fitzgerald BUY $26.00
21 Aug 2026 Truist Financial BUY $20.00
11 Aug 2026 J.P. Morgan BUY $11.00
10 Aug 2026 H.C. Wainwright BUY $25.00
7 Aug 2026 Needham BUY $19.00
7 Aug 2026 Citi BUY $14.00
6 Aug 2026 William Blair BUY –
1 Jul 2026 H.C. Wainwright BUY $25.00
4 Jun 2026 Citi BUY $14.00
3 Jun 2026 H.C. Wainwright BUY $25.00
22 May 2026 J.P. Morgan BUY $11.00
18 May 2026 Wedbush BUY $16.00
15 May 2026 Wedbush BUY $16.00
15 May 2026 H.C. Wainwright BUY $20.00

Discussion

No comments yet — be the first to weigh in on SLDB.

Leave a comment

Scroll to Top